Archive for March, 2009
Go Ahead, Pharma: Social Media Okay, says FDA
Big pharmaceuticals have been extraordinarily cautious when it comes to social media as a venue for reaching their customers. A quick search in Facebook yields groups set up primarily for employees, or fan pages that were set up because somebody was bored at work one day, but nothing of substance that I can point to [...]
Bald Ambition: Searching for a Hair-Loss Remedy
Can biotech offer a solution to hair loss? Hostogen thinks it can. Its new product, ReGenica, is based on proteins harvested from stem cells and has shown promise in its Phase 1 clinical trials. Can’t wait until that product is on the market? Propecia is always another option, and has now shown that it could actually help prevent prostate cancer in men.
Genetics and Gene Therapy: A New Frontier
As I was researching this post, most of the blogosphere was abuzz about President Obama’s executive order allowing federal funding for stem cell research (see the IAmBiotech article here). It has been largely received by the community as an important first step towards treating and possibly curing many debilitating diseases that exist today. While I [...]
Trouble for Wyeth & Pfizer, and Merck buys Schering-Plough
On March 4th, Wyeth and its suitor Pfizer received a wallop in a Supreme Court case of Wyeth v. Levine, in which a Vermont woman named Diana Levine was awarded $6.7 million in damages for an incident in which their antihistamine drug Phenergan (promethazine) may have led to loss of Levine’s arm due to gangrene. [...]
Love your Coffee
My wife LOVES her coffee. In fact, the only time I can ever remember in our nearly 12 years together that she didn’t drink it daily was during her pregnancy with both our two-year-old son and our daughter, who will probably be arriving any day now. For a long time I was not a coffee [...]
Loading ...